Unique ID issued by UMIN | UMIN000003065 |
---|---|
Receipt number | R000003719 |
Scientific Title | A double-blind placebo-controlled clinical trial of botulinum toxin type A injection therapy in patients with Japanese cedar pollinosis 2010 |
Date of disclosure of the study information | 2010/01/25 |
Last modified on | 2017/10/03 19:52:38 |
A double-blind placebo-controlled clinical trial of botulinum toxin type A injection therapy in patients with Japanese cedar pollinosis 2010
Effect of Botrinum Toxin Type A Therapy in Patients with Japanese cedar pollinosis (E-BOAT study 2)
A double-blind placebo-controlled clinical trial of botulinum toxin type A injection therapy in patients with Japanese cedar pollinosis 2010
Effect of Botrinum Toxin Type A Therapy in Patients with Japanese cedar pollinosis (E-BOAT study 2)
Japan |
Japanese cedar pollinosis
Oto-rhino-laryngology |
Others
NO
To investigate the efficacy and safety of botulinum toxin type A in patients with Japnese cedar pollinosis
Safety,Efficacy
Confirmatory
Pragmatic
Symptom score, Medication score, QOL estimation, rhinomanometry
adverse events
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Dose comparison
NO
NO
Institution is considered as a block.
YES
Central registration
3
Treatment
Medicine |
One ml (20U) of botulinum toxin type A is injecjected into each inferior turbinate just before the beggining of pollen scattering. Loratadine (10mg)and/or Betamethasone/d-Chlorpheniramine Maleate can be used as a backup drug.
One ml (10U) of botulinum toxin type A is injecjected into each inferior turbinate just before the beggining of pollen scattering. Loratadine (10mg) and/or Betamethasone/d-Chlorpheniramine Maleate can be used as a backup drug.
One ml saline is injecjected into each inferior turbinate just before the beggining of pollen scattering. Loratadine (10m) and/or Betamethasone/d-Chlorpheniramine Maleate can be used as a backup drug.
18 | years-old | <= |
59 | years-old | > |
Male and Female
1) a history of Japanese cedar pollinosis
2) CAP-RAST aginst Jananese cedar pollen >=2
1) pregnancy or possibility of pregnancy
2) history of heart desease
3) history of glaucoma
4) history of prostate hypertrophy
5) history of neuro-muscular desiases
6) history of stroke
7) accampanying acute rhinitis or sinusitis
8) use of any anti-allergy drugs at the beginning of the study
10) prominent deviation of the nasal septum
45
1st name | |
Middle name | |
Last name | Keisuke Masuyama |
University of Yamanashi
Department of Otorhinolaryngoloty, Head and Neck Surgery
1110 Shimokato, Chuo, Yamanashi, Japan
055-273-6769
akamijo@yamaanshi.ac.jp
1st name | |
Middle name | |
Last name | Atsushi Kamijo |
University of Yamanashi
Department of Otorhinolaryngoloty, Head and Neck Surgery
1110 Shimokato, Chuo, Yamanashi, Japan
055-273-6769
akamijyo@yamanashi.ac.jp
Department of Otorhinolaryngology, Head and Neck Surgery
Faculty of Medicine, University of Yamanashi
NONE
Self funding
NO
2010 | Year | 01 | Month | 25 | Day |
Unpublished
Completed
2009 | Year | 12 | Month | 09 | Day |
2010 | Year | 01 | Month | 01 | Day |
2010 | Year | 04 | Month | 01 | Day |
2010 | Year | 04 | Month | 01 | Day |
2010 | Year | 04 | Month | 01 | Day |
2010 | Year | 12 | Month | 01 | Day |
2010 | Year | 01 | Month | 20 | Day |
2017 | Year | 10 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003719